Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 42 of 42 entries
Sorted by: Best Match Show Resources per page
Trazodone Add-on in COVID-19-related Selective Serotonin Reuptake Inhibitor-resistant Post-traumatic Stress Disorder in Healthcare Workers: Two Case Reports.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Berardis D, Fornaro M, Ventriglio A, Valchera A, Vellante F, Pettorruso M, Martinotti G, Fraticelli S, Giannantonio MD.
PMID: 34690132
Clin Psychopharmacol Neurosci. 2021 Nov 30;19(4):780-785. doi: 10.9758/cpn.2021.19.4.780.

COVID-19 represents a significant stress factor for all people worldwide due to several factors, including quarantine, lockdowns, fear of contagion, deaths, and other traumatic events. However, the healthcare workers (HCWs) have paid the higher price of this pandemic in...

Cite
Berardis D, Fornaro M, Ventriglio A, et al. Trazodone Add-on in COVID-19-related Selective Serotonin Reuptake Inhibitor-resistant Post-traumatic Stress Disorder in Healthcare Workers: Two Case Reports. Clin Psychopharmacol Neurosci. 2021;19(4):780-785doi: 10.9758/cpn.2021.19.4.780.
Berardis, D., Fornaro, M., Ventriglio, A., Valchera, A., Vellante, F., Pettorruso, M., Martinotti, G., Fraticelli, S., & Giannantonio, M. D. (2021). Trazodone Add-on in COVID-19-related Selective Serotonin Reuptake Inhibitor-resistant Post-traumatic Stress Disorder in Healthcare Workers: Two Case Reports. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 19(4), 780-785. https://doi.org/10.9758/cpn.2021.19.4.780
Berardis, Domenico De, et al. "Trazodone Add-on in COVID-19-related Selective Serotonin Reuptake Inhibitor-resistant Post-traumatic Stress Disorder in Healthcare Workers: Two Case Reports." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 19,4 (2021): 780-785. doi: https://doi.org/10.9758/cpn.2021.19.4.780
Berardis D, Fornaro M, Ventriglio A, Valchera A, Vellante F, Pettorruso M, Martinotti G, Fraticelli S, Giannantonio MD. Trazodone Add-on in COVID-19-related Selective Serotonin Reuptake Inhibitor-resistant Post-traumatic Stress Disorder in Healthcare Workers: Two Case Reports. Clin Psychopharmacol Neurosci. 2021 Nov 30;19(4):780-785. doi: 10.9758/cpn.2021.19.4.780. PMID: 34690132; PMCID: PMC8553539.
Copy Download .nbib Format: NLM
Rapid response to selective serotonin reuptake inhibitors in post-COVID depression.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Mazza MG, Zanardi R, Palladini M, Rovere-Querini P, Benedetti F.
PMID: 34634679
Eur Neuropsychopharmacol. 2022 Jan;54:1-6. doi: 10.1016/j.euroneuro.2021.09.009. Epub 2021 Oct 09.

The spreading of the Severe Acute Respiratory Syndrome Coronavirus (COVID-19) pandemic could be associated with psychiatric implications. After COVID-19, depression was reported in 40% of patients at one-, three-, and six-months follow-up. Emerging literature suggests anti-inflammatory and antiviral properties...

Cite
Mazza MG, Zanardi R, Palladini M, et al. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol. 2021;54:1-6doi: 10.1016/j.euroneuro.2021.09.009.
Mazza, M. G., Zanardi, R., Palladini, M., Rovere-Querini, P., & Benedetti, F. (2022). Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 541-6. https://doi.org/10.1016/j.euroneuro.2021.09.009
Mazza, Mario Gennaro, et al. "Rapid response to selective serotonin reuptake inhibitors in post-COVID depression." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology vol. 54 (2022): 1-6. doi: https://doi.org/10.1016/j.euroneuro.2021.09.009
Mazza MG, Zanardi R, Palladini M, Rovere-Querini P, Benedetti F. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol. 2022 Jan;54:1-6. doi: 10.1016/j.euroneuro.2021.09.009. Epub 2021 Oct 09. PMID: 34634679; PMCID: PMC8500775.
Copy Download .nbib Format: NLM
[Pharmacological treatment of obesity].

Anales del sistema sanitario de Navarra

Salvador J, Silva C, Santos E.
PMID: 12861278
An Sist Sanit Navar. 2002;25:143-61. doi: 10.23938/ASSN.0822.

The foundation on which the treatment of obesity rests is made up of the procedures aimed at unbalancing the equation of energy balance in favour of calorie consumption. Pharmacological treatment is aimed at favouring a reduction of calorie intake...

Cite
Salvador J, Silva C, Santos E. Tratamiento farmacológico de la obesidad. [Pharmacological treatment of obesity]. An Sist Sanit Navar. 2002;25:143-61doi: 10.23938/ASSN.0822.
Salvador, J., Silva, C., & Santos, E. (2002). Tratamiento farmacológico de la obesidad. [Pharmacological treatment of obesity]. Anales del sistema sanitario de Navarra, 25143-61. https://doi.org/10.23938/ASSN.0822
Salvador, J, et al. "Tratamiento farmacológico de la obesidad." [Pharmacological treatment of obesity]. Anales del sistema sanitario de Navarra vol. 25 (2002): 143-61. doi: https://doi.org/10.23938/ASSN.0822
Salvador J, Silva C, Santos E. Tratamiento farmacológico de la obesidad. [Pharmacological treatment of obesity]. An Sist Sanit Navar. 2002;25:143-61. doi: 10.23938/ASSN.0822. Spanish. PMID: 12861278.
Copy Download .nbib Format: NLM
Antidepressant use and diabetes mellitus risk: a meta-analysis.

Korean journal of family medicine

Yoon JM, Cho EG, Lee HK, Park SM.
PMID: 23904952
Korean J Fam Med. 2013 Jul;34(4):228-40. doi: 10.4082/kjfm.2013.34.4.228. Epub 2013 Jul 24.

BACKGROUND: Epidemiologic studies have reported inconsistent findings regarding the association between the use of antidepressants and type 2 diabetes mellitus (DM) risk. We performed a meta-analysis to systematically assess the association between antidepressants and type 2 DM risk.METHODS: We...

Cite
Yoon JM, Cho EG, Lee HK, et al. Antidepressant use and diabetes mellitus risk: a meta-analysis. Korean J Fam Med. 2013;34(4):228-40doi: 10.4082/kjfm.2013.34.4.228.
Yoon, J. M., Cho, E. G., Lee, H. K., & Park, S. M. (2013). Antidepressant use and diabetes mellitus risk: a meta-analysis. Korean journal of family medicine, 34(4), 228-40. https://doi.org/10.4082/kjfm.2013.34.4.228
Yoon, Jae Moon, et al. "Antidepressant use and diabetes mellitus risk: a meta-analysis." Korean journal of family medicine vol. 34,4 (2013): 228-40. doi: https://doi.org/10.4082/kjfm.2013.34.4.228
Yoon JM, Cho EG, Lee HK, Park SM. Antidepressant use and diabetes mellitus risk: a meta-analysis. Korean J Fam Med. 2013 Jul;34(4):228-40. doi: 10.4082/kjfm.2013.34.4.228. Epub 2013 Jul 24. PMID: 23904952; PMCID: PMC3726790.
Copy Download .nbib Format: NLM
Rapid response to selective serotonin reuptake inhibitors in post-COVID depression.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Mazza MG, Zanardi R, Palladini M, Rovere-Querini P, Benedetti F.
PMID: 34634679
Eur Neuropsychopharmacol. 2022 Jan;54:1-6. doi: 10.1016/j.euroneuro.2021.09.009. Epub 2021 Oct 09.

The spreading of the Severe Acute Respiratory Syndrome Coronavirus (COVID-19) pandemic could be associated with psychiatric implications. After COVID-19, depression was reported in 40% of patients at one-, three-, and six-months follow-up. Emerging literature suggests anti-inflammatory and antiviral properties...

Cite
Mazza MG, Zanardi R, Palladini M, et al. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol. 2021;54:1-6doi: 10.1016/j.euroneuro.2021.09.009.
Mazza, M. G., Zanardi, R., Palladini, M., Rovere-Querini, P., & Benedetti, F. (2022). Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 541-6. https://doi.org/10.1016/j.euroneuro.2021.09.009
Mazza, Mario Gennaro, et al. "Rapid response to selective serotonin reuptake inhibitors in post-COVID depression." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology vol. 54 (2022): 1-6. doi: https://doi.org/10.1016/j.euroneuro.2021.09.009
Mazza MG, Zanardi R, Palladini M, Rovere-Querini P, Benedetti F. Rapid response to selective serotonin reuptake inhibitors in post-COVID depression. Eur Neuropsychopharmacol. 2022 Jan;54:1-6. doi: 10.1016/j.euroneuro.2021.09.009. Epub 2021 Oct 09. PMID: 34634679; PMCID: PMC8500775.
Copy Download .nbib Format: NLM
Antidepressant Use and the Risk of Major Adverse Cardiovascular Events in Patients Without Known Cardiovascular Disease: A Retrospective Cohort Study.

Frontiers in pharmacology

Jang HY, Kim JH, Song YK, Shin JY, Lee HY, Ahn YM, Oh JM, Kim IW.
PMID: 33362548
Front Pharmacol. 2020 Dec 10;11:594474. doi: 10.3389/fphar.2020.594474. eCollection 2020.

No abstract available.

Cite
Jang HY, Kim JH, Song YK, et al. Antidepressant Use and the Risk of Major Adverse Cardiovascular Events in Patients Without Known Cardiovascular Disease: A Retrospective Cohort Study. Front Pharmacol. 2020;11:594474doi: 10.3389/fphar.2020.594474.
Jang, H. Y., Kim, J. H., Song, Y. K., Shin, J. Y., Lee, H. Y., Ahn, Y. M., Oh, J. M., & Kim, I. W. (2020). Antidepressant Use and the Risk of Major Adverse Cardiovascular Events in Patients Without Known Cardiovascular Disease: A Retrospective Cohort Study. Frontiers in pharmacology, 11594474. https://doi.org/10.3389/fphar.2020.594474
Jang, Ha Young, et al. "Antidepressant Use and the Risk of Major Adverse Cardiovascular Events in Patients Without Known Cardiovascular Disease: A Retrospective Cohort Study." Frontiers in pharmacology vol. 11 (2020): 594474. doi: https://doi.org/10.3389/fphar.2020.594474
Jang HY, Kim JH, Song YK, Shin JY, Lee HY, Ahn YM, Oh JM, Kim IW. Antidepressant Use and the Risk of Major Adverse Cardiovascular Events in Patients Without Known Cardiovascular Disease: A Retrospective Cohort Study. Front Pharmacol. 2020 Dec 10;11:594474. doi: 10.3389/fphar.2020.594474. eCollection 2020. PMID: 33362548; PMCID: PMC7758770.
Copy Download .nbib Format: NLM
Showing 37 to 42 of 42 entries